Name
Osaühing Surju Tervisekeskus
Registry code
10315360
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
18.11.1997 (27)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
86211 - Provision of general medical treatment
480 399 €
196 923 €
41%
2 570 €
(estimate is approximate)
207 011 €
4
Submitted
No tax arrears
95%
84%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Ülle Alanurm 03.06.1960 (64) | 100% - 2 556.00 EUR | Board member | Direct ownership |
| 2019 26.05.2020 | 2020 03.06.2021 | 2021 09.06.2022 | 2022 08.03.2023 | 2023 25.04.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 279 678 € | 311 180 € | 353 707 € | 391 164 € | 480 399 € |
| Net profit (loss) for the period | 78 250 € | 96 333 € | 137 432 € | 152 588 € | 196 923 € |
| Profit Margin | 28% | 31% | 39% | 39% | 41% |
| Current Assets | 256 062 € | 343 881 € | 461 951 € | 598 323 € | 231 524 € |
| Fixed Assets | 31 451 € | 24 193 € | 16 935 € | 9 677 € | 2 419 € |
| Total Assets | 287 513 € | 368 074 € | 478 886 € | 608 000 € | 233 943 € |
| Current Liabilities | 18 778 € | 23 006 € | 21 386 € | 22 913 € | 26 932 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 268 735 € | 345 068 € | 457 500 € | 585 087 € | 207 011 € |
| Employees | 4 | 4 | 4 | 4 | 4 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 19 393.66 € | 20 389.24 € | 6 |
| 2023 Q4 | - | 15 222.1 € | 15 993.73 € | 6 |
| 2023 Q3 | - | 15 940.4 € | 16 658.92 € | 6 |
| 2023 Q2 | - | 19 924.98 € | 16 250.27 € | 7 |
| 2023 Q1 | - | 14 962.28 € | 15 533.92 € | 7 |
| 2022 Q4 | - | 12 631.12 € | 13 085.4 € | 7 |
| 2022 Q3 | - | 18 112.7 € | 14 328.24 € | 6 |
| 2022 Q2 | - | 11 670.35 € | 12 068.05 € | 6 |
| 2022 Q1 | - | 14 063.08 € | 14 537.14 € | 6 |
| 2021 Q4 | - | 10 493.33 € | 10 849.07 € | 6 |
| 2021 Q3 | - | 16 921.67 € | 12 845.86 € | 6 |
| 2021 Q2 | - | 12 490.78 € | 12 911.2 € | 7 |
| 2021 Q1 | - | 12 028.39 € | 12 454.97 € | 6 |
| 2020 Q4 | - | 10 044.7 € | 10 387.7 € | 6 |
| 2020 Q3 | - | 15 809.48 € | 12 378.87 € | 6 |
| 2020 Q2 | - | 10 239.82 € | 10 670.41 € | 6 |
| 2020 Q1 | - | 11 838.88 € | 12 363.51 € | 6 |
